TRTürkçe
ENEnglish
AZAzərbaycanca
UZO‘zbekcha
ARالعربية
FRFrançais
DEDeutsch
RUРусский
GDP and Pharmaceutical GMP: Temperature Mapping Guide
Pharmaceutical GMP concerns manufacturing controls; GDP concerns medicines distribution. Start with the actual activity, entity, premises and country, then identify the relevant authorisation and inspection route. A GDP document is not a general manufacturing permission.
Pharmaceutical GMP concerns manufacturing controls; GDP concerns medicines distribution. Start with the actual activity, entity, premises and country, then identify the relevant authorisation and inspection route. A GDP…
Choose the programme by the actual medicine activity
Pharmaceutical GMP concerns manufacturing controls; GDP concerns medicines distribution. Start with the actual activity, entity, premises and country, then identify the relevant authorisation and inspection route. A GDP document is not a general manufacturing permission.
Keep this pharmaceutical comparison separate from food GMP/GHP and cosmetic ISO 22716. Similar acronyms do not make their scopes interchangeable. List proposed changes explicitly, especially when a distribution business intends to add a production operation, and confirm the required route with the competent authority.
Distinguish mapping from one calibrated measurement
Temperature mapping examines how conditions vary across the relevant storage area. The EU human-medicine GDP guideline links initial mapping under representative conditions to subsequent monitoring positions. A logger's calibration addresses the measuring device; it does not show the spatial behaviour of the whole store.
Hypothetically, a wholesaler plans medicine-bottle filling and presents one calibrated logger beside a cooling outlet as ‘GDP mapping’. Separate two questions: the proposed production activity and its applicable regulatory route; and the storage study's actual coverage. Check the area, operating conditions, measurement plan and results rather than accepting the certificate title on the logger.
Use the evidence for the right decision
The preparation file should distinguish activity classification, authorisation records, mapping evidence and ongoing monitoring. Record limitations and any missing technical work. A satisfactory temperature study does not establish pharmaceutical manufacturing compliance or make every medicine batch usable.
Kayra can coordinate the agreed scope comparison and document-gap review. The business supplies authentic operational information; qualified technical work and responsible product decisions remain with the relevant parties. Competent authorities determine the applicable regulatory route and official compliance; consultancy does not replace them.
Official sources
This guide separates pharmaceutical programme scope, spatial temperature evidence and authorisation. It does not confer manufacturing permission or decide medicine-batch usability.
Are pharmaceutical GMP and GDP interchangeable?
No. Identify the actual manufacturing or distribution activity and its applicable requirements.
Does calibration alone establish mapping?
No. Device accuracy and spatial temperature distribution are different questions.
Can a GDP map authorise medicine production?
No. Confirm the production activity's regulatory route with the competent authority.
Tell us what you need and our specialists will contact you.
The exact records for GDP and GMP Difference, Temperature Mapping Guide depend on the confirmed scope. Current, consistent and traceable information reduces avoidable revisions.